Sign in

CIK 0001376339

  • Large accelerated filer

MIMEDX GROUP, INC.

Sign in to watch
Ticker
MDXG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
EIN
262792552
Phone
+1 770-651-9100
Business address
1775 W OAK COMMONS COURT, NE, MARIETTA, GA, 30062
Former names
Alynx, Co.
  1. 4 Grant or award Chief Operating Officer acquired 58,478 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 58,478 shares (grant or award)
  3. 4 Open-market sale Chief Operating Officer sold 30,764 shares at an average $8.04 ($247,426)
  4. 4 Open-market sale Chief Operating Officer sold 31,043 shares at an average $8.05 ($249,763)
  5. 4 Conversion 10% owner acquired 28,195,249 shares (conversion)
  6. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $7.16 ($35,787)
  7. 4 Grant or award Chief Financial Officer acquired 97,200 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market buy Chief Executive Officer bought 100,000 shares at an average $6.40 ($640,434)
  10. 4 Grant or award Director acquired 35,354 shares (grant or award)
  11. 4 Grant or award Director acquired 35,354 shares (grant or award)
  12. 4 Grant or award Director acquired 35,354 shares (grant or award)
  13. 4 Grant or award Director acquired 35,354 shares (grant or award)
  14. 4 Grant or award Director acquired 35,354 shares (grant or award)
  15. 4 Grant or award Director acquired 35,354 shares (grant or award)
  16. 4 Grant or award Director acquired 35,354 shares (grant or award)
  17. 4 Open-market sale President, Regenerative Med. sold 13,972 shares at an average $6.00 ($83,798)
  18. 4 Open-market sale General Counsel and CAO sold 5,870 shares at $5.93 ($34,786)
  19. 4 Open-market sale President, Regenerative Med. sold 5,869 shares at $5.93 ($34,780)
  20. 4 Open-market sale Chief Accounting Officer sold 1,595 shares at $5.93 ($9,452)

Page 4 of 30 · 584 filings